UBX · Categories · Form 4

UBX - SEC Form 4 insider transactions

Unity Biotechnology Inc. (UBX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for UBX

• 427d
  CLO and Head of Ops Nguyen Alexander Hieu sold $18,388 worth of shares (17,852 units at $1.03), decreasing direct ownership by 27% to 48,753 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 427d
  CFO & Head of Corp. Dev. Sullivan Lynne Marie sold $22,523 worth of shares (21,867 units at $1.03), decreasing direct ownership by 18% to 98,905 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 427d
  Chief Executive Officer Ghosh Anirvan sold $99,701 worth of shares (96,797 units at $1.03), decreasing direct ownership by 39% to 153,454 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 430d
  CLO and Head of Ops Nguyen Alexander Hieu sold $2,267 worth of shares (1,954 units at $1.16) and was granted 44,000 shares, increasing direct ownership by 171% to 66,605 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 430d
  CFO & Head of Corp. Dev. Sullivan Lynne Marie was granted 65,000 shares, increasing direct ownership by 117% to 120,772 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 430d
  Chief Executive Officer Ghosh Anirvan was granted 175,000 shares, increasing direct ownership by 233% to 250,251 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 451d
  SEC Form 4 filed by Director Hashad Yehia

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 484d
  CFO & Head of Corp. Dev. Sullivan Lynne Marie sold $341 worth of shares (153 units at $2.23), decreasing direct ownership by 0.27% to 55,772 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 484d
  CLO and Head of Ops Nguyen Alexander Hieu sold $366 worth of shares (164 units at $2.23), decreasing direct ownership by 0.66% to 24,559 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 484d
  Chief Executive Officer Ghosh Anirvan sold $1,432 worth of shares (642 units at $2.23), decreasing direct ownership by 0.85% to 75,251 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 497d
  SEC Form 4 filed by CLO and Head of Ops Nguyen Alexander Hieu

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 497d
  SEC Form 4 filed by CFO & Head of Corp. Dev. Sullivan Lynne Marie

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 497d
  SEC Form 4 filed by Chief Executive Officer Ghosh Anirvan

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 513d
  SEC Form 4 filed by Chief Medical Officer Grossi Federico

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 575d
  CFO & Head of Corp. Dev. Sullivan Lynne Marie sold $175 worth of shares (136 units at $1.29), decreasing direct ownership by 0.24% to 55,925 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 575d
  Chief Legal Officer Nguyen Alexander Hieu sold $192 worth of shares (149 units at $1.29), decreasing direct ownership by 0.60% to 24,723 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 575d
  Chief Executive Officer Ghosh Anirvan sold $557 worth of shares (432 units at $1.29), decreasing direct ownership by 0.57% to 75,893 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 667d
  Chief Legal Officer Nguyen Alexander Hieu sold $236 worth of shares (154 units at $1.53), decreasing direct ownership by 0.62% to 24,872 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 667d
  Chief Executive Officer Ghosh Anirvan sold $924 worth of shares (604 units at $1.53), decreasing direct ownership by 0.79% to 76,325 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 667d
  CFO & Head of Corp. Dev. Sullivan Lynne Marie sold $213 worth of shares (139 units at $1.53), decreasing direct ownership by 0.25% to 56,061 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 708d
  Chief Legal Officer Nguyen Alexander Hieu sold $109 worth of shares (78 units at $1.40), decreasing direct ownership by 0.31% to 25,026 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 708d
  Chief Executive Officer Ghosh Anirvan sold $1,700 worth of shares (1,214 units at $1.40), decreasing direct ownership by 2% to 76,929 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 708d
  CFO & Head of Corp. Dev. Sullivan Lynne Marie sold $454 worth of shares (324 units at $1.40), decreasing direct ownership by 0.98% to 32,685 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 713d
  SEC Form 4 filed by Director Samuels Camille D

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 713d
  SEC Form 4 filed by Director Leonard Keith R

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 713d
  SEC Form 4 filed by Director Roberts Margo R

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 713d
  SEC Form 4 filed by Director O'Neill Gilmore Neil

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 713d
  SEC Form 4 filed by Director Berns Paul L

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 713d
  SEC Form 4 filed by Director David Nathaniel E

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 713d
  SEC Form 4 filed by Director Samar Michael P.

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 762d
  Ghosh Anirvan sold $935 worth of shares (603 units at $1.55), decreasing direct ownership by 0.77% to 78,143 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 799d
  Nguyen Alexander Hieu was granted 20,000 shares, increasing direct ownership by 392% to 25,104 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 850d
  Ghosh Anirvan sold $1,163 worth of shares (680 units at $1.71), decreasing direct ownership by 0.86% to 78,746 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 855d
  Ghosh Anirvan sold $2,023 worth of shares (1,183 units at $1.71), decreasing direct ownership by 1% to 79,426 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 944d
  Ghosh Anirvan sold $1,078 worth of shares (589 units at $1.83), decreasing direct ownership by 0.73% to 80,609 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 947d
  Ghosh Anirvan sold $1,946 worth of shares (1,024 units at $1.90), decreasing direct ownership by 1% to 81,198 units (SEC Form 4)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 993d
  SEC Form 4: Ghosh Anirvan sold $3,078 worth of shares (1,246 units at $2.47), decreasing direct ownership by 1% to 82,222 units

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1036d
  SEC Form 4: Ghosh Anirvan sold $1,708 worth of shares (581 units at $2.94), decreasing direct ownership by 0.69% to 83,468 units

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1038d
  SEC Form 4: Ghosh Anirvan sold $2,917 worth of shares (1,020 units at $2.86), decreasing direct ownership by 1% to 84,049 units

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1073d
  SEC Form 4 filed by Ghosh Anirvan

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1074d
  SEC Form 4 filed by Samuels Camille D

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1074d
  SEC Form 4 filed by O'Neill Gilmore Neil

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1074d
  SEC Form 4 filed by Berns Paul L

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1074d
  SEC Form 4 filed by Roberts Margo R

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1074d
  SEC Form 4 filed by Samar Michael P.

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1074d
  SEC Form 4 filed by Leonard Keith R

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1074d
  SEC Form 4 filed by David Nathaniel E

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1085d
  SEC Form 4 filed by Ghosh Anirvan

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1119d
  SEC Form 4 filed by Sullivan Lynne Marie

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1119d
  SEC Form 4 filed by Nguyen Alexander Hieu

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1119d
  SEC Form 4 filed by Ghosh Anirvan

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1128d
  SEC Form 4 filed by Ghosh Anirvan

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1129d
  SEC Form 4 filed by Ghosh Anirvan

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1158d
  SEC Form 4 filed by Ghosh Anirvan

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1158d
  SEC Form 4 filed by Dananberg Jamie

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1177d
  SEC Form 4: Dananberg Jamie sold $4,020 worth of shares (1,005 units at $4.00) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 63,237 units (for tax liability)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1177d
  SEC Form 4: Ghosh Anirvan sold $4,840 worth of shares (1,210 units at $4.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 91,025 units to satisfy withholding tax

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1217d
  SEC Form 4: Dananberg Jamie sold $4,177 worth of shares (863 units at $4.84) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 64,242 units to cover withholding tax

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1217d
  SEC Form 4: Ghosh Anirvan sold $12,453 worth of shares (2,573 units at $4.84) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 92,235 units (withholding obligation)

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)
• 1220d
  SEC Form 4: Ghosh Anirvan sold $5,073 worth of shares (1,140 units at $4.45) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 94,808 units to satisfy withholding obligation

  4 - Unity Biotechnology, Inc. (0001463361) (Issuer)

Other UBX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends